💊 Levodopa and carbidopa (Carbidopa And Levodopa)
Levodopa and carbidopa (extended-release tablets) is used to treat Parkinson's disease and related parkinsonism. Levodopa replaces dopamine in the brain, while carbidopa lets more levodopa reach the brain. The dose must be carefully titrated by your doctor.
In Arabic: ليفودوبا وكاربيدوبا✅ What it is used for
- Treatment of Parkinson's disease
- Treatment of post-encephalitic parkinsonism
- Treatment of symptomatic parkinsonism that may follow carbon monoxide or manganese intoxication
🧪 Active ingredient
Levodopa: an amino acid converted to dopamine in the brain, relieving Parkinson's symptoms. Carbidopa: inhibits breakdown of levodopa outside the brain so more levodopa reaches the brain; it does not enter the brain itself.
🌿 Benefits
- Relieves Parkinson's symptoms such as tremor, rigidity and slowness of movement
- May allow better mobility
- Adding carbidopa lets more levodopa reach the brain
📝 How to use
- The daily dose is set carefully and gradually by your doctor based on your response; do not change it on your own.
- Extended-release tablets should be swallowed whole and not chewed or crushed.
- Doses are usually spaced 4 to 8 hours apart during the waking day, as your doctor directs.
- Patients are monitored closely during dose adjustment, particularly for involuntary movements and nausea.
- It can be used with vitamin B6 (pyridoxine) supplements; vitamin B6 levels should be checked before treatment and periodically during it.
💊 Dosage forms
- Extended-release tablets 25 mg carbidopa / 100 mg levodopa
- Extended-release tablets 50 mg carbidopa / 200 mg levodopa
⚠️ Common side effects
- Dyskinesia (involuntary movements)
- Nausea
- Hallucinations
- Confusion
- Dizziness
- Depression
- Headache
- Abnormal dreams
- Vomiting
- Dry mouth
- Insomnia
- Diarrhea
- Loss of appetite
🚨 Serious — seek medical help
- Depression with suicidal tendencies
- Psychotic episodes with delusions and paranoid ideation
- Seizures
- Upper gastrointestinal bleeding in people with a history of peptic ulcer
- Cardiac irregularities or fainting
- Angioedema, urticaria and bullous skin reactions
- Pathological gambling, hypersexuality and impulse control symptoms
- Peripheral neuropathy
⛔ Do not use if
- Use of nonselective monoamine oxidase (MAO) inhibitors (must be stopped at least two weeks before starting)
- Known hypersensitivity to any component of the drug
- Narrow-angle glaucoma
❗ Warnings & precautions
- When switching from levodopa alone, it must be stopped at least 12 hours before starting this medicine.
- Dyskinesias may be greater than with regular tablets and may require a dose reduction.
- Watch for depression with suicidal tendencies.
- Use with caution in severe cardiovascular or pulmonary disease, bronchial asthma, and renal, hepatic or endocrine disease.
- Patients with prior myocardial infarction and residual arrhythmias need careful cardiac monitoring during initial dose adjustment.
- May increase the chance of upper gastrointestinal bleeding in patients with a history of peptic ulcer.
- Vitamin B6 levels should be evaluated before and periodically during treatment because deficiency can cause problems including seizures.
- Absorption of levodopa may be impaired in some patients on a high-protein diet.
🔄 Drug interactions
- Nonselective MAO inhibitors: contraindicated.
- Selegiline (MAO-B inhibitor): may be associated with severe orthostatic hypotension.
- Antihypertensive drugs: symptomatic postural hypotension may occur; dose adjustment may be needed.
- Tricyclic antidepressants: rare reports of hypertension and dyskinesia.
- Dopamine D2 antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid: may reduce levodopa's effect.
- Phenytoin and papaverine: reported to reverse the benefit of levodopa.
- Reserpine, tetrabenazine and other monoamine-depleting drugs: use not recommended.
- Iron salts or multivitamins containing iron: may reduce bioavailability; use together with caution.
- Metoclopramide: may increase levodopa bioavailability but may worsen disease control through dopamine receptor antagonism.
🤰 Pregnancy
There are no adequate, well-controlled studies in pregnant women. Animal studies showed visceral and skeletal malformations in rabbits and fewer live pups in rats. Levodopa crosses the human placenta. In women of childbearing potential, use only if the expected benefit outweighs possible hazards to mother and child, as decided by the doctor.
🍼 Breastfeeding
Levodopa has been detected in human milk. Caution should be exercised when used by a nursing woman; consult your doctor.
🧒 Children
Safety and effectiveness in pediatric patients have not been established. Use below the age of 18 is not recommended.
👴 Older adults
No overall meaningful differences in safety or effectiveness were seen between older and younger patients, but greater sensitivity of some older individuals to adverse reactions such as hallucinations cannot be ruled out. There is no specific dosing recommendation; the dose is titrated to clinical effect and tolerability.
🌡️ Storage
Store at 20° to 25°C (excursions permitted 15° to 30°C) in a tightly closed container, protected from light and moisture.
⏰ Missed dose
The label does not state what to do for a missed dose. Ask your doctor or pharmacist and do not double the dose on your own.
🆘 Overdose
For overdose, general supportive measures are used with immediate gastric lavage, judicious intravenous fluids, maintenance of an airway, and ECG monitoring for arrhythmias. Pyridoxine is not effective in reversing the drug's actions. Seek emergency medical help immediately.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Levodopa is the metabolic precursor of dopamine, crosses the blood-brain barrier, and is presumably converted to dopamine in the brain. Carbidopa inhibits peripheral decarboxylation of levodopa, does not cross the blood-brain barrier, and does not affect levodopa metabolism within the CNS, making more levodopa available to the brain. Carbidopa:levodopa ratio in this product is 1:4; levodopa bioavailability from the extended-release tablet is about 70% to 75% relative to standard tablets.
Labeled dosing
The daily dosage is determined by careful titration with close monitoring for dyskinesias and nausea. When converting from immediate-release tablets, substitute a dose providing approximately 10% more levodopa per day, which may be increased to up to 30% more depending on clinical response. The dosing interval is 4 to 8 hours during the waking day. Tablets should not be chewed or crushed. The individual dose is set by the doctor or pharmacist.
- Evaluate vitamin B6 levels before initiation, periodically, and as clinically indicated; supplement per standard of care if low.
- Standard anti-Parkinson drugs (other than levodopa without a decarboxylase inhibitor) may be used concomitantly, with dose adjustment as needed.
- When switching from levodopa alone, discontinue it at least 12 hours before starting.
- Can be given to patients receiving pyridoxine supplements since carbidopa prevents pyridoxine's reversal of levodopa effects.
- Laboratory abnormalities reported include decreased hemoglobin and hematocrit, elevated serum glucose, and white blood cells, bacteria and blood in the urine.
🎓 Key points for students
- Carbidopa is a peripheral aromatic amino acid decarboxylase inhibitor that does not cross the blood-brain barrier.
- Levodopa competes with certain amino acids for transport across the gut wall, so absorption may be reduced with a high-protein diet.
- Motor complications include end-of-dose failure, peak-dose dyskinesia and the 'on-off' phenomenon.
- Extended-release tablets use a polymer-based delivery system that slowly erodes to release the drug.
- Nonselective MAO inhibitors are contraindicated, whereas selective MAO-B inhibitors may be used at recommended doses.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is levodopa/carbidopa used for?
It is used to treat Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide or manganese intoxication.
Can I chew or crush the tablet?
No. Extended-release tablets must be swallowed whole without chewing or crushing.
What are the most common side effects?
The most common are dyskinesia (involuntary movements), nausea, hallucinations, confusion, dizziness and depression. Tell your doctor about any worrying symptoms.
Can I take it with vitamin B6 supplements?
Yes, it can be given to patients taking vitamin B6 supplements, and vitamin B6 levels should be checked before and periodically during treatment.
Is it suitable for children or pregnant women?
Use below age 18 is not recommended, and in pregnancy it is used only if the doctor judges the benefit outweighs the risk.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-06), simplified. Updated: 2026-11-15.